National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 41074-41075 [2021-16306]
Download as PDF
<![CDATA[
41074
Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Deafness and
Other Communication Disorders
Advisory Council.
This is a virtual meeting and will be
open to the public as indicated below.
The url link to this meeting is: https://
www.nidcd.nih.gov/about/advisorycouncil/upcoming-meetings. The
meeting is partially Closed to the public.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Deafness and
Other Communication Disorders Advisory
Council.
Date: September 9–10, 2021.
Closed: September 9, 2021, 10:00 a.m. to
12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Open: September 9, 2021, 1:00 p.m. to 3:10
p.m.
Agenda: Staff reports on divisional,
programmatical, and special activities.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Open: September 10, 2021, 10:00 a.m. to
12:00 p.m.
Agenda: Staff reports on divisional,
programmatical, and special activities.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Rebecca Wagenaar-Miller,
Ph.D., Director, Division of Extramural
Activities, NIDCD/NIH, 6001 Executive
Boulevard, Bethesda, MD 20892, (301) 496–
8693, rebecca.wagenaar-miller@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
VerDate Sep<11>2014
17:24 Jul 29, 2021
Jkt 253001
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcd.nih.gov/about/advisory-council,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: July 27, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–16305 Filed 7–29–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: SBIR/STTR Commercialization
Readiness Pilot Program.
Date: August 18, 2021.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Allen Richon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7892, Bethesda, MD 20892, 301–379–
9351, allen.richon@nih.hhs.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
Dated: July 27, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–16307 Filed 7–29–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; PAR–19–202: High
Impact, Interdisciplinary Science in NIDDK
Research Areas (RC2)—Diabetes,
Endocrinology & Metabolic Diseases.
Date: September 20, 2021.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Lan Tian, Ph.D., Scientific
Review Officer, National Institute of Diabetes
and Digestive and Kidney Diseases, National
Institutes of Health, 6707 Democracy
Boulevard, Room 7349, Bethesda, MD 20892–
5452, (301) 496–7050, email: tianl@nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Review of
Institutional Training Grants in Digestive
Diseases and Nutrition.
Date: September 24, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Video
Meeting).
Contact Person: Lan Tian, Ph.D., Scientific
Review Officer, National Institute of Diabetes
and Digestive and Kidney Diseases, National
Institutes of Health, 6707 Democracy
Boulevard, Room 7349, Bethesda, MD 20892–
5452, (301) 496–7050, email: tianl@nih.gov.
E:\FR\FM\30JYN1.SGM
30JYN1
Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: July 27, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–16306 Filed 7–29–21; 8:45 am]
BILLING CODE 4140–01–P
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nibib.nih.gov/about-nibib/advisorycouncil, where an agenda and any additional
information for the meeting will be posted
when available.
Dated: July 26, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–16262 Filed 7–29–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HOMELAND
SECURITY
National Institutes of Health
National Institue of Biomedical
Imaging and Bioengineering; Notice of
Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Biomedical Imaging and
Bioengineering.
The meeting will be open to the
public by videocast as indicated below.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Biomedical Imaging and
Bioengineering NACBIB, September 2021.
Date: September 14, 2021.
Open: 12:00 p.m. to 3:15 p.m.
Agenda: Report from the Institute Director
and other Institute Staff.
Place: National Institutes of Health,
Democracy II, 6707 Democracy Boulevard,
Bethesda, MD 20892 (Virtual Meeting).
Closed: 3:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, 6707 Democracy Boulevard,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David T. George, Ph.D.,
Associate Director, Office of Research
Administration, National Institute of
Biomedical Imaging and Bioengineering,
6707 Democracy Boulevard, Room 920,
Bethesda, MD 20892, georged@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
VerDate Sep<11>2014
17:24 Jul 29, 2021
Jkt 253001
Coast Guard
[Docket No. USCG–2021–0242]
Great Lakes Pilotage Advisory
Committee Meeting
U.S. Coast Guard, Department
of Homeland Security.
ACTION: Notice of Federal Advisory
Committee Meeting.
AGENCY:
The Great Lakes Pilotage
Advisory Committee (Committee) will
meet in Cape Vincent, New York, to
discuss matters relating to Great Lakes
pilotage, including review of proposed
Great Lakes pilotage regulations and
policies. The meeting will be open to
the public.
DATES:
Meeting: The Committee will meet on
Wednesday, September 1, 2021, from 8
a.m. to 5:30 p.m. Eastern Daylight Time.
Please note that this meeting may
adjourn early if the Committee has
completed its business.
Comments and supporting
documentations: To ensure your
comments are received by Committee
members before the meeting, submit
your written comments no later than
August 24, 2021.
ADDRESSES: The meeting will be held at
the Saint Lawrence Seaway Pilots’
Association conference facility, 230 N
Point Street, Cape Vincent, NY 13618.
Pre-registration Information: Preregistration is not required for access.
Attendees will be required to follow as
closely as possible COVID–19 safety
guidelines promulgated by the Centers
for Disease Control and Prevention
(CDC), which includes vaccinated
persons do not need to wear masks.
Masks will be provided for nonvaccinated attendees. Some CDC
guidance is here: https://www.cdc.gov/
coronavirus/2019-ncov/communication/
guidance.html
SUMMARY:
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
41075
For information on facilities or
services for individuals with disabilities
or to request special assistance at the
meeting, contact the individual listed in
the FOR FURTHER INFORMATION CONTACT
section of this notice.
Instructions: You are free to submit
comments at any time, including orally
at the meeting, but if you want
Committee members to review your
comment before the meeting, please
submit your comments no later than
August 24, 2021. We are particularly
interested in comments on the issues in
the ‘‘Agenda’’ section below. We
encourage you to submit comments
through the Federal eRulemaking Portal
at https://www.regulations.gov. If your
material cannot be submitted using
https://www.regulations.gov, call or
email the individual in the FOR FURTHER
INFORMATION CONTACT section of this
document for alternate instructions. You
must include the words ‘‘Department of
Homeland Security’’ and the docket
number USCG–2021–0242. Comments
received will be posted without
alteration at https://
www.regulations.gov, including any
personal information provided. You
may wish to view the Privacy and
Security Notice available on the
homepage of www.regulations.gov, and
DHS’s eRulemaking System of Records
notice (85FR 14226, March 11, 2020). If
you encounter technical difficulties
with comment submission, contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section of this
notice.
Docket Search: Documents mentioned
in this notice as being available in the
docket, and all public comment, will be
in our online docket at https://
www.regulations.gov and can be viewed
by following that website’s instructions.
Additionally, if you go to the online
docket and sign-up for email alerts, you
will be notified when comments are
posted.
Mr.
Vincent Berg, Alternate Designated
Federal Officer of the Great Lakes
Pilotage Advisory Committee, telephone
(202) 906–0835, or email
Vincent.F.Berg@uscg.mil.
FOR FURTHER INFORMATION CONTACT:
Notice of
this meeting is in compliance with the
Federal Advisory Committee Act (5
U.S.C. Appendix). The Great Lakes
Pilotage Advisory Committee is
established under the authority of 46
U.S.C. 9307, and makes
recommendations to the Secretary of
Homeland Security and the Coast Guard
on matters relating to Great Lakes
pilotage, including review of proposed
SUPPLEMENTARY INFORMATION:
E:\FR\FM\30JYN1.SGM
30JYN1
]]>Agencies
[Federal Register Volume 86, Number 144 (Friday, July 30, 2021)]
[Notices]
[Pages 41074-41075]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16306]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; PAR-19-202: High Impact,
Interdisciplinary Science in NIDDK Research Areas (RC2)--Diabetes,
Endocrinology & Metabolic Diseases.
Date: September 20, 2021.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Lan Tian, Ph.D., Scientific Review Officer,
National Institute of Diabetes and Digestive and Kidney Diseases,
National Institutes of Health, 6707 Democracy Boulevard, Room 7349,
Bethesda, MD 20892-5452, (301) 496-7050, email: [email protected].
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Review of Institutional
Training Grants in Digestive Diseases and Nutrition.
Date: September 24, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Video Meeting).
Contact Person: Lan Tian, Ph.D., Scientific Review Officer,
National Institute of Diabetes and Digestive and Kidney Diseases,
National Institutes of Health, 6707 Democracy Boulevard, Room 7349,
Bethesda, MD 20892-5452, (301) 496-7050, email: [email protected].
[[Page 41075]]
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: July 27, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-16306 Filed 7-29-21; 8:45 am]
BILLING CODE 4140-01-P
